Comparative effectiveness of glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors on noninvasive indices of hepatic steatosis and fibrosis in patients with type 2 diabetes mellitus

Publication date: Available online 28 September 2020Source: Diabetes & Metabolic Syndrome: Clinical Research & ReviewsAuthor(s): Evangelia Makri, Marina Kita, Antonis Goulas, Paraskevi Papaioannidou, Zoe A. Efstathiadou, Fotini Adamidou, Stergios A. Polyzos
Source: Diabetes and Metabolic Syndrome: Clinical Research and Reviews - Category: Endocrinology Source Type: research